- Previous Close
4.0100 - Open
4.0000 - Bid 4.0000 x --
- Ask 4.0100 x --
- Day's Range
3.9500 - 4.0100 - 52 Week Range
2.9800 - 6.7100 - Volume
12,681,200 - Avg. Volume
23,223,118 - Market Cap (intraday)
5.59B - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 29, 2020
- 1y Target Est
--
Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China.
www.gzbl.com6,582
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002424.SZ
View MorePerformance Overview: 002424.SZ
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002424.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002424.SZ
View MoreValuation Measures
Market Cap
5.59B
Enterprise Value
7.25B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.35
Price/Book (mrq)
1.61
Enterprise Value/Revenue
1.72
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.04%
Return on Assets (ttm)
-4.01%
Return on Equity (ttm)
-12.36%
Revenue (ttm)
4.23B
Net Income Avi to Common (ttm)
-466.78M
Diluted EPS (ttm)
-0.3400
Balance Sheet and Cash Flow
Total Cash (mrq)
170.62M
Total Debt/Equity (mrq)
52.50%
Levered Free Cash Flow (ttm)
228.45M